Elan Corporation plc Company Profile Complimentary D&B Business Overview on over 38 million companies with Free Registration!

Elan Corporation plc

Treasury Building
Lower Grand Canal Street
Dublin 2
Republic of Ireland
Tel: 353/1/709-4000
URL: http://www.elan.ie
Primary Symbol & Exchange:
DRX - Ordinary Shares - Irish
Other Symbols & Exchanges:
ELN - ADR - New York Stock Exchange
ELA - Dual listed - London
Industry:
Pharmaceutical
+  SIC Industry Code:
+  NAICS Industry Code:
Mergers & Acquisitions:
Elan Corporation plc Mergers and Acquisitions
Thomson Financial Business Description:
The Group's principal activity is discovering, developing, manufacturing and marketing advanced therapies in neurodegenerative diseases, autoimmune diseases and severe pain. The Group's operations are carried out through two divisions. Elan Drug Technologies focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry. Biopharmaceuticals relates to the research, development and commercial activities in the areas of autoimmune diseases, neurodegenerative diseases and specialty business. The Group's product brands are Azactam, Maxipime, NanoCrystal, Naprelan, Prialt, Tysabri and Verelan.
Alacra Alerts: Elan Corporation plc RSS Feed  Subscribe with My Yahoo!
Receive alerts on the latest reports on Elan Corporation plc

Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.

Premium Content Results:







Search for more premium content on Elan Corporation plc
  about us contact us public company index private company index pcan widget your privacy rights terms & conditions